Literature DB >> 28458344

Effects of Astragalus Combined with Angelica on Bone Marrow Hematopoiesis Suppression Induced by Cyclophosphamide in Mice.

Fei Li1, Rong Tang2, Ling-Bo Chen2, Ke-Sheng Zhang2, Xiao-Ping Huang1, Chang-Qing Deng1.   

Abstract

Danggui Buxue Tang (DBT), a combination of Astragalus and Angelica at a 5 : 1 ratio, mainly promotes hematopoiesis. However, in the clinic, the combination ratio of Astragalus and Angelica to treat low hematopoietic function is not an absolute 5 : 1 ratio, suggesting that the herbs may promote hematopoiesis better after being combined at a certain range of ratios. The objective of this study is to investigate the effect of different ratio combinations of Astragalus and Angelica on bone marrow hematopoiesis suppression induced by cyclophosphamide (CTX) and to probe the interaction and mechanism of Astragalus combined with Angelica in promoting hematopoiesis. Following establishment of the model, mice were administered with Astragalus (6.00 g·kg-1), Angelica (3.00 g·kg-1), and combinations of Astragalus and Angelica at different ratios, including 10 : 1 (Astragalus 9.81 g·kg-1+Angelica 0.98 g·kg-1), 5 : 1 (Astragalus 9.00 g·kg-1+Angelica 1.80 g·kg-1), 2 : 1 (Astragalus 7.71 g·kg-1+Angelica 3.08 g·kg-1), 1 : 1 (Astragalus 5.40 g·kg-1+Angelica 5.40 g·kg-1), 1 : 2.5 (Astragalus 3.08 g·kg-1+Angelica 7.71 g·kg-1), 1 : 5 (Astragalus 1.80 g·kg-1+Angelica 9.00 g·kg-1), and 1 : 10 (Astragalus 0.98 g·kg-1+Angelica 9.81 g·kg-1). Our results suggested that Astragalus mixed with Angelica synergistically promoted hematopoiesis best when the combination ratio of Astragalus and Angelica was 1 : 1, 1 : 2.5 or 1 : 5; moreover, the effect of Angelica was greater than that of Astragalus. The potential mechanisms of the combinations of Astragalus and Angelica that promote hematopoiesis include the dissolution of the effective components, promoting the synthesis and secretion of hematopoietic growth factor (HGF) and the proliferation of hematopoietic progenitor cells (HPCs).

Entities:  

Keywords:  Angelica; Astragalus; bone marrow hematopoiesis suppression; chemical component; hematopoietic growth factor (HGF); hematopoietic progenitor cell (HPC)

Mesh:

Substances:

Year:  2017        PMID: 28458344     DOI: 10.1248/bpb.b16-00802

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Systems-Based Interactome Analysis for Hematopoiesis Effect of Angelicae sinensis Radix: Regulated Network of Cell Proliferation towards Hemopoiesis.

Authors:  Guang Zheng; He Zhang; Yun Yang; Ying-Li Sun; Yan-Jing Zhang; Ju-Ping Chen; Ting Hao; Cheng Lu; Hong-Tao Guo; Ge Zhang; Dan-Ping Fan; Xiao-Juan He; Ai-Ping Lu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

Review 2.  The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.

Authors:  Chen-Chen Ma; Yue-Hua Jiang; Yan Wang; Rui-Rong Xu
Journal:  Curr Med Sci       Date:  2022-10-17

3.  Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function Against Cyclophosphamide-Induced Injury in Mice and t-BHP-Induced Injury in HSCs.

Authors:  Wei Zhang; Jia-Huan Zhu; Hao Xu; Xiao-Ping Huang; Xiao-Dan Liu; Chang-Qing Deng
Journal:  Front Pharmacol       Date:  2019-08-22       Impact factor: 5.988

4.  Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation.

Authors:  Shi-Han Feng; Bin Zhao; Xue Zhan; Retsepile Motanyane; Shu-Mei Wang; Ao Li
Journal:  Drug Des Devel Ther       Date:  2021-02-24       Impact factor: 4.162

5.  Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling.

Authors:  Jiahuan Tong; Zhisong Wu; Yuchen Wang; Qingxun Hao; Haoge Liu; Fang Cao; Yang Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-02       Impact factor: 2.629

6.  Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC.

Authors:  Bin Yu; Guangyao Lv; Muhammad Sohail; Zhiyong Li; Yanli Li; Meiyu Yu; Fuyou Sun; Hui Xu
Journal:  Dis Markers       Date:  2022-02-26       Impact factor: 3.434

7.  The therapeutic effect of modified Huangqi Guizhi Wuwu Tang for multiple myeloma: An 18-year follow-up case report.

Authors:  Mingmin Tian; Huang Huang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus-Angelica Combination.

Authors:  Huifang Yan; Xiwei Peng; Hao Xu; Jiahuan Zhu; Changqing Deng
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-13       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.